Research Article
LncRNA CAR10 Upregulates PDPK1 to Promote Cervical Cancer Development by Sponging miR-125b-5p
Table 1
Clinical characteristics of 40 cervical cancer patients.
| Clinicopathologic feature | n (%) | CAR10 (mean ± SEM) | p value |
| Age | | | | ≤50 | 22 (55.00%) | 2.11 ± 0.22 | | ≥50 | 18 (45.00%) | 2.07 ± 0.24 | |
| Menopause | | | | Yes | 24 (60.00%) | 2.47 ± 0.21 | | No | 16 (40.00%) | 2.38 ± 0.22 | |
| Histology | | | | Squamous cell cancer | 20 (50.00%) | 1.98 ± 0.15 | | Adenocarcinoma | 14 (35.00%) | 2.03 ± 0.19 | | Others | 6 (15.00%) | 2.10 ± 0.2 | |
| Differentiation | | | | Well to moderate | 30 (75.00%) | 2.14 ± 0.22 | | Poor | 10 (25.00%) | 3.62 ± 0.41 | |
| Grade number (%) | | | | I | 6 (15.00%) | 1.11 ± 0.18 | | II | 20 (50.00%) | 2.23 ± 0.31 | | III | 14 (35.00%) | 3.51 ± 0.38 | |
| Tumor size | | | | <4 cm | 26 (65.00%) | 2.35 ± 0.27 | | ≥4 cm | 14 (35.00%) | 2.16 ± 0.30 | |
| Lymph node | | | | Negative | 30 (75.00%) | 2.12 ± 0.21 | | Positive | 10 (25.00%) | 2.21 ± 0.18 | |
|
|